News | News By Subject | News by Disease News By Date | Search News

Diabetes Mellitus News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Novartis AG (NVS) Launches New Portfolio Of Affordable Medicines for Poor Countries     9/24/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Phenomix Corporation Announces Positive Results from a Phase 3 Study of Dutogliptin in Type 2 Diabetes Mellitus     4/20/2010
Exelixis, Inc. (EXEL) (Jobs) Diabetic Nephropathy Drug Trial Fails Goal     10/16/2007
US FDA Delays Decision For Sanofi-Aventis (France) (SASY.PA) Inhaled Insulin     10/28/2005
Pfizer Inc. (PFE) Release: Exubera(R) Receives Positive Opinion From CHMP For The Treatment Of Type 1 And Type 2 Diabetes     10/13/2005
Positive Diabetes Drug Study Boosts Amylin Pharmaceuticals, Inc. (AMLN) Stock     8/23/2005
OSI Pharmaceuticals, Inc. (OSIP) Announces Acquisition Of All Minority Interest Shares Of Prosidion Limited, (OSIP) UK-Based Diabetes And Obesity Subsidiary     4/18/2005
Depomed, Inc. (DEPO) , Biovail Corporation (BVF) Update Status Of Glumetza NDA     4/13/2005
Perlegen Sciences, Inc. Licenses Late-Stage Compound From Mitsubishi Pharma Corporation; Companies Usher In New Era Of Personalized Medicines In Metabolic Disease     4/13/2005
Bristol-Myers Squibb Company (BMY) Carries Out Promised Job Cuts At Its Facilities In New York And New Jersey     11/17/2004
FDA Approves OptiClik(TM), New Insulin Pen System From Aventis S.A. (AVE)     8/12/2004
Aventis Pharmaceuticals, Inc. (AVE) Receives FDA Approval Of Its Rapid-Acting Insulin Analogue Apidra     4/20/2004

News from Around the Web

Press Releases
New Biovista Publication: EMR Data Confirm Big Data Analytics Prediction That Hypothyroidism Is A Risk Factor For New-Onset Diabetes Mellitus     6/23/2015
Evoke Pharma, Inc. Announces The Completion Of Enrollment In Its Thorough ECG Study For EVK-001     9/9/2014
Evoke Pharma, Inc. Announces Initiation Of A Thorough ECG (QT) Study For EVK-001     8/12/2014
Resverlogix Corporation (RVX.TO) Secures An Additional $30 Million From Citibank Loan     7/7/2014
Resverlogix Corporation (RVX.TO) Completes Enrollment Of Phase 2 Clinical Trial Of RVX-208 In Patients With Pre-Diabetes Mellitus     12/23/2013
Tranzyme Pharma Announces Positive Results from Phase 2 Study of Oral TZP-102 (Ghrelin Agonist) in Patients with Diabetic Gastroparesis     6/29/2010
Generex Biotechnology Corporation (GNBT) Receives Positive Responses From Independent Physicians and Nurse Practitioners in Recent Focus Groups Conducted in the United States for Generex Oral-lyn(TM)     3/11/2010
Halozyme Therapeutics, Inc. (HALO) Announces Phase I Clinical Trial Results Demonstrating Results of Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humilin R® and With Humalog®     6/9/2008
Tissera, Inc. Reports Achievement of Proof of Concept of the Curative Effect of Its Transplantation Technology in Large Animal Diabetic Model     1/8/2008
American Association of Clinical Endocrinologists Publishes New Diabetes Mellitus Clinical Practice Guidelines     8/22/2007
Tissera, Inc. Reports Significant Milestone Achievement in Its Large Animal Diabetic Model Studies     8/8/2007
Opexa Therapeutics (OPXA) Advances Monocyte Derived Islet Technology to Proof of Principle in stz-induced NOD/SCID Mice     6/27/2007
American Association of Clinical Endocrinologists Release: Study Reveals "Missing Link" Between Pre-Diabetes and Type 2 Diabetes Mellitus (T2DM)     3/21/2007
Tissera, Inc. Reports Encouraging Preliminary Results Of Its Large Animal Diabetic Model Experiments Of Pancreatic Xenotransplantation     12/6/2006
MannKind Biopharmaceuticals (MNKD) Presents Safety And Efficacy Data On Inhaled Technosphere(R) Insulin At American Diabetes Association's 65th Scientific Sessions     6/14/2005

//-->